Published on
Cancer cachexia, weakness and wasting of the body due to cancer, can be a serious issue for lung cancer patients. And medical experts, such as Dr. Phillip Bonomi at Rush Medical Center in Chicago, Illinois, talked with Andrew Schorr on location at the World Conference on Lung Cancer (WCLC) in Denver, Colorado about the newest FDA-approved drug, anamorelin. Anamorelin shows promise in preventing weight loss, increasing muscle mass, and in some studies, even showed indications of improving fatigue symptoms. Watch as Dr. Bonomi expounds on this extremely important breakthrough for lung cancer patients.
View more programs featuring Andrew Schorr
Produced in association with Patient Empowerment Network and LUNGevity Foundation
Become a member to access our latest content and be the first to know about new programs and information.
From the International Association for the Study of Lung Cancer World Conference in Denver, experts discuss the "autobahn of oncology" concept: high speed regulatory administration with low fatalities.
Published:
